In parallel, investigations indicated that IL-1β blocking has cooperated with anti-PD-1 treatment in reducing tumor growth in a mouse breast cancer model [47] and that IL-1β could up-regulate PD-L1 expression [48,49]. The gene discussed is IL1B; the disease is breast carcinoma.